title: Hybrid-genetic algorithm based descriptor optimization and QSAR models for predicting the biological activity of Tipranavir analogs for HIV protease inhibition.
abstract: The prediction of biological activity of a chemical compound from its structural features plays an important role in drug design. In this paper, we discuss the quantitative structure activity relationship (QSAR) prediction models developed on a dataset of 170 HIV protease enzyme inhibitors. Various chemical descriptors that encode hydrophobic, topological, geometrical and electronic properties are calculated to represent the structures of the molecules in the dataset. We use the hybrid-GA (genetic algorithm) optimization technique for descriptor space reduction. The linear multiple regression analysis (MLR), correlation-based feature selection (CFS), non-linear decision tree (DT), and artificial neural network (ANN) approaches are used as fitness functions. The selected descriptors represent the overall descriptor space and account well for the binding nature of the considered dataset. These selected features are also human interpretable and can be used to explain the interactions between a drug molecule and its receptor protein (HIV protease). The selected descriptors are then used for developing the QSAR prediction models by using the MLR, DT and ANN approaches. These models are discussed, analyzed and compared to validate and test their performance for this dataset. All three approaches yield the QSAR models with good prediction performance. The models developed by DT and ANN are comparable and have better prediction than the MLR model. For ANN model, weight analysis is carried out to analyze the role of various descriptors in activity prediction. All the prediction models point towards the involvement of hydrophobic interactions. These models can be useful for predicting the biological activity of new untested HIV protease inhibitors and virtual screening for identifying new lead compounds.
authors.affiliation: Department of Biomedical Engineering, University of California-Davis, Davis, CA 95616-5294, USA. sralla@ucdavis.edu
authors.forename: A Srinivas
authors.initials: AS
authors.lastname: Reddy
authors.forename: Sunil
authors.initials: S
authors.lastname: Kumar
authors.forename: Rajni
authors.initials: R
authors.lastname: Garg
mesh_terms: D000465:Algorithms; D015195:Drug Design; D017320:HIV Protease Inhibitors / Q000737:chemistry*; D006801:Humans; D008958:Models, Molecular; D015394:Molecular Structure; D011725:Pyridines / Q000737:chemistry*; D011753:Pyrones / Q000737:chemistry*; D021281:Quantitative Structure-Activity Relationship; D013449:Sulfonamides
chemical_list: D017320:HIV Protease Inhibitors; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; C107201:tipranavir
references.citation: IEEE Trans Neural Netw. 2008 May;19(5):836-44
references.pmid: 18467212
references.citation: J Chem Inf Comput Sci. 2004 Mar-Apr;44(2):716-26
references.pmid: 15032554
references.citation: Expert Opin Emerg Drugs. 2006 May;11(2):217-30
references.pmid: 16634698
references.citation: J Med Chem. 2004 Apr 22;47(9):2356-64
references.pmid: 15084134
references.citation: J Chem Inf Comput Sci. 2003 Jul-Aug;43(4):1200-7
references.pmid: 12870912
references.citation: J Chem Inf Model. 2008 Jan;48(1):213-9
references.pmid: 18163603
references.citation: Ann Chim. 2007 Jan-Feb;97(1-2):69-83
references.pmid: 17822265
references.citation: IEEE Trans Neural Netw. 2005 Jan;16(1):263-74
references.pmid: 15732405
references.citation: J Chem Inf Model. 2005 Jul-Aug;45(4):1109-21
references.pmid: 16045306
references.citation: Science. 1986 May 9;232(4751):697
references.pmid: 3008335
references.citation: Top HIV Med. 2008 Dec;16(5):138-45
references.pmid: 19106428
references.citation: IEEE/ACM Trans Comput Biol Bioinform. 2007 Jul-Sep;4(3):476-484
references.pmid: 17666767
references.citation: J Infect. 2008 Jul;57(1):1-10
references.pmid: 18556070
references.citation: Chem Rev. 1999 Dec 8;99(12):3525-3602
references.pmid: 11849030
references.citation: Bioinformatics. 2003 Jan;19(1):98-107
references.pmid: 12499299
references.citation: J Chem Inf Comput Sci. 2004 Jul-Aug;44(4):1257-66
references.pmid: 15272833
references.citation: J Chem Inf Comput Sci. 2000 May;40(3):659-67
references.pmid: 10850771
references.citation: Chem Rev. 1996 Dec 19;96(8):3147-3176
references.pmid: 11848856
references.citation: Bioorg Med Chem Lett. 2005 Aug 15;15(16):3767-70
references.pmid: 15993582
references.citation: Curr Med Chem. 2003 Sep;10(17):1679-88
references.pmid: 12871116
references.citation: Bioorg Med Chem. 2005 Jun 2;13(12):4078-84
references.pmid: 15911321
references.citation: Neural Netw. 1999 Jan;12(1):145-151
references.pmid: 12662723
references.citation: Curr Top Med Chem. 2006;6(1):31-9
references.pmid: 16454756
references.citation: Bioinformatics. 2004 Oct 12;20(15):2479-81
references.pmid: 15073010
references.citation: Bioorg Med Chem Lett. 2006 Apr 1;16(7):1869-73
references.pmid: 16480871
references.citation: J Infect Dis. 2003 Sep 1;188(5):653-60
references.pmid: 12934180
references.citation: Chem Res Toxicol. 2008 Dec;21(12):2229-36
references.pmid: 19548346
references.citation: Mini Rev Med Chem. 2008 Mar;8(3):213-21
references.pmid: 18336341
references.citation: Biosystems. 2003 Nov;72(1-2):149-58
references.pmid: 14642664
references.citation: Curr Drug Discov Technol. 2007 Oct;4(3):141-9
references.pmid: 17985997
references.citation: Mini Rev Med Chem. 2007 Nov;7(11):1097-107
references.pmid: 18045213